- Ghana submit by 1 Feb in advance of 7 Feb 2024 deadline (5 March as backup)
- RDD will notify of supporting documents needed for the IRB
- Training - R&D/ISGlobal
- Good Clinical Practice (can be GFDA or from different organization as long as not expired)
- Good Clinical Practice (can be GFDA or from different organization as long as not expired)
- Reference lab
- Samples should be run on site (Kato Katz in the schools) and others in-country (ELISA dried blood spots for Strongyloides), with a lab in Accra still to be identified.